Janku, Filip <br/><br/>
Outcomes of phase II clinical trials with single-agent therapies in advanced/metastatic non-small cell lung cancer published between 2000 and 2009.  [electronic resource] 

 -  Clinical cancer research : an official journal of the American Association for Cancer Research  Nov 2012 
 - 6356-63 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1557-3265 
<br/><br/><label>Standard No.: </label>10.1158/1078-0432.CCR-12-0178  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--therapeutic use<br/>Carcinoma, Non-Small-Cell Lung--drug therapy<br/>Clinical Trials, Phase II as Topic<br/>Disease-Free Survival<br/>Gefitinib<br/>Humans<br/>Lung Neoplasms--drug therapy<br/>Molecular Targeted Therapy<br/>Multicenter Studies as Topic<br/>Multivariate Analysis<br/>Quinazolines--therapeutic use<br/>Treatment Outcome